Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study

dc.contributor.author
Gomila Grange, Aina
dc.contributor.author
Carratalà, Jordi
dc.contributor.author
Eliakim-Raz, Noa
dc.contributor.author
Shaw Perujo, Evelyn
dc.contributor.author
Tebé, Cristian
dc.contributor.author
Wolkewitz, Martin
dc.contributor.author
Wiegand, Irith
dc.contributor.author
Grier, Sally
dc.contributor.author
Vank, Christiane
dc.contributor.author
Cuperus, Nienke
dc.contributor.author
van den Heuvel, Leonard
dc.contributor.author
Vuong, Cuong
dc.contributor.author
MacGowan, Alasdair
dc.contributor.author
Leibovici, Leonard
dc.contributor.author
Addy, Ibironke
dc.contributor.author
Pujol Rojo, Miquel
dc.date.issued
2020-07-08T07:17:26Z
dc.date.issued
2020-07-08T07:17:26Z
dc.date.issued
2019-12-03
dc.date.issued
2020-07-06T08:26:16Z
dc.identifier
https://hdl.handle.net/2445/168077
dc.identifier
706888
dc.identifier
31827779
dc.description.abstract
Background: Although catheter-associated urinary tract infection (CA-UTI) is a major healthcare-related problem worldwide, there is a scarcity of current data from countries with high antimicrobial resistance rates. We aimed to determine the clinical outcomes of patients with CA-UTI compared to those of patients with other sources of complicated urinary tract infection (cUTI), and to assess the impact of antimicrobial resistance. We also aimed to identify the factors influencing 30-day mortality among patients with CA-UTI. Methods: This was a multicentre, multinational retrospective cohort study including hospitalised adults with cUTI between January 2013 and December 2014 in twenty hospitals from eight countries from southern Europe, Turkey and Israel. The primary endpoint was 30-day mortality. The secondary endpoints were length of hospital stay, symptom improvement after 7 days' treatment, symptom recurrence at 30 days and readmission 60 days after hospital discharge. Results: Of the 807 cUTI episodes, 341 (42.2%) were CA-UTIs. The time from catheter insertion to cUTI diagnosis was less than 2 weeks in 44.6% of cases. Overall, 74.5% of cases had hospital or healthcare-acquired CA-UTI. Compared to patients with other cUTI aetiologies, those with CA-UTI had the following characteristics: they were more frequently males, older, admitted for a reason other than cUTI and admitted from a long-term care facility; had higher Charlson's comorbidity index; and more frequently had polymicrobial infections and multidrug-resistant Gram-negative bacteria (MDR-GNB). Patients with CA-UTI also had significantly higher 30-day mortality rates (15.2% vs 6%) and longer hospital stay (median 14 [interquartile range -IQR- 7-27] days vs 8 [IQR 5-14] days) than patients with cUTI of other sources. After adjusting for confounders, CA-UTI was not independently associated with an increased risk of mortality (odds ratio, 1.40; 95% confidence interval, 0.77-2.54), and neither was the presence of MDR-GNB. Conclusions: CA-UTI was the most frequent source of cUTI, affecting mainly frail patients. The mortality of patients with CA-UTI was high, though this was not directly related to the infection.
dc.format
8 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
BioMed Central
dc.relation
Reproducció del document publicat a: https://doi.org/10.1186/s13756-019-0656-6
dc.relation
Antimicrobial Resistance And Infection Control, 2019-12-03, vol. 8, num. 198
dc.relation
https://doi.org/10.1186/s13756-019-0656-6
dc.rights
cc by (c) Gomila, Aina et al., 2019
dc.rights
http://creativecommons.org/licenses/by/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Ciències Clíniques)
dc.subject
Resistència als medicaments
dc.subject
Infeccions del tracte urinari
dc.subject
Malalts hospitalitzats
dc.subject
Drug resistance
dc.subject
Urinary tract infections
dc.subject
Hospital patients
dc.title
Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)